- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotics for the treatment of hepatic encephalopathy
Authors
Keywords
Rifaximin, Neomycin, Covert hepatic encephalopathy, Metronidazole, Vancomycin, Economics
Journal
METABOLIC BRAIN DISEASE
Volume 28, Issue 2, Pages 307-312
Publisher
Springer Nature
Online
2013-02-07
DOI
10.1007/s11011-013-9383-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
- (2012) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
- (2012) Georgios N. Kalambokis et al. Clinical Gastroenterology and Hepatology
- In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience
- (2012) Jasmohan S. Bajaj et al. HEPATOLOGY
- Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
- (2011) A. Sanyal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis
- (2011) Jasmohan S. Bajaj et al. HEPATOLOGY
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
- (2011) Javier Fernández et al. HEPATOLOGY
- Durability of Rifaximin Response in Hepatic Encephalopathy
- (2011) Guy W. Neff et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Review article: the modern management of hepatic encephalopathy
- (2010) J. S. BAJAJ ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy
- (2010) Oliviero Riggio et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
- (2010) Sandeep Singh Sidhu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy
- (2010) Jasmohan S. Bajaj et al. GASTROENTEROLOGY
- Drug therapy: Rifaximin1
- (2010) Jasmohan S. Bajaj et al. HEPATOLOGY
- Rifaximin in hepatic encephalopathy: More than just a non-absorbable antibiotic?
- (2010) Rajiv Jalan JOURNAL OF HEPATOLOGY
- Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis
- (2010) D.L. Shawcross et al. JOURNAL OF HEPATOLOGY
- Mechanisms, diagnosis and management of hepatic encephalopathy
- (2010) Ravi Prakash et al. Nature Reviews Gastroenterology & Hepatology
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rifaximin for the Treatment of Hepatic Encephalopathy
- (2010) P.S. Mantry et al. TRANSPLANTATION PROCEEDINGS
- Severe sepsis in cirrhosis
- (2009) Thierry Gustot et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now